Specific interest should be placed on continuing to study HGF, procalcitonin, IL-8, IL-2Rα, IP-10, and CXCL-5, as they were the most prevalent biomarkers selected in models of adverse outcomes from CDI in this study. This evidence concerns the gene CXCL5 and clostridium difficile infection.